A total of 65 million adults have reported a recent incidence of back pain. In total, there are 16 million adults who deal with chronic back pain. During your lifetime, you have an 80 percent chance of you dealing with at least one episode of chronic lower back pain. Unfortunately, […]
Zogenix (ZGNX) caught my eye recently as a potential newly minted biotech high-flyer. As I began looking into it I saw it has an interesting story with an uncertain outcome, one that promises many interesting twists. This article sets out my analysis of it as an investment vehicle. I am […]
As the US Food and Drug Administration (FDA) focuses on other issues, companies, both big and small, are looking to boost physician and consumer interest in their “medical foods” — products that fall somewhere between drugs and supplements and promise to mitigate symptoms, or even address underlying pathologies, of a […]
By The Canningma‘s Matan Weil, provided exclusively to Benzinga Cannabis. Discovered by scientists in the early 1990s, the endocannabinoid system is responsible for regulating many basic functions throughout the body. The system can be activated by cannabinoids that are naturally created by the body — and those found in the […]
Cannabis plants have a variety of uses in today’s age and they have been in use for hundreds of years throughout history. Not only is marijuana fun to smoke, but the hemp plant can provide materials for making clothes, rope, paper, and be used for medicinal purposes. The recent buzz […]
GW Pharmaceuticals (NASDAQ:GWPH) and Cara Therapeutics (NASDAQ:CARA) often get lumped together as cannabinoid-focused biotechs. However, that label is really only applicable to GW Pharmaceuticals. Although Cara Therapeutics has done some preclinical testing on a cannabinoid receptor agonist and holds some patents on cannabinoid compounds, the company doesn’t really focus on cannabinoid […]
LINCOLN — At times, everything, including a pandemic, seemed stacked against advocates of medical marijuana in Nebraska. But Nebraskans for Medical Marijuana celebrated Thursday as they turned in more than 182,000 petition signatures, gathered from all 93 Nebraska counties, to the Secretary of State’s Office. That’s enough signatures to make […]
CBD Hemp Oil Market was valued US$ XX Bn in 2019 and is expected to reach US$ XX Bn by 2027, at a XX% CAGR of around XX% during a forecast period. The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers […]
Drugs policy Mother of Alfie Dingley says parents are despondent at lack of access to full-extract oil Alfie Dingley, pictured with his mother, Hannah Deacon, is one of only two children to be prescribed full-extract medicinal cannabis oil by the NHS. Photograph: Maggie Deacon/PA There have been no new NHS […]
FDA: Medical cannabis policy As things stand, the FDA has legalised exactly one cannabis-derived drug product, Epidiolex (cannabidiol). The institution has also approved three synthetic drugs, Marinol (dronabinol), Syndros (dronabinol), and Cesamet (nabilone). The cannabinoid (CBD) product, Epidiolex, is only used in cases of two rare, severe forms of epilepsy. […]
